Actively managed fund

Candriam Equities L Oncology I GBP Cap

ISIN
LU1864482515

How good is this fund, really?

See the rating in the app

About Candriam Equities L Oncology I GBP Cap

Companies worldwide involved in fighting cancer, from treatments and diagnostics to medical equipment, services and dedicated technologies, make up Candriam Equities L Oncology I GBP Cap. The sub-fund of the Candriam Equities L SICAV, managed by Candriam, seeks capital growth, aims to beat the MSCI World Health Care Index (Net Return) and pursues a long-term social impact. Stocks pass three filters: thematic exposure to oncology, an assessment of clinical data and a fundamental review covering management, growth, competitive edge, value creation and debt. Candriam's ESG analysis is integrated, low-rated companies are avoided, and companies breaching international norms or exposed to certain controversial activities are excluded. Expected tracking error is above 4%. This class I share reinvests income. Ongoing charges are 1.00%; risk is 6 of 7, and a holding period of at least six years is suggested.

Watch this fund for free Add Candriam Equities L Oncology I GBP Cap to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy Candriam Equities L Oncology I GBP Cap — platforms and fees

Sold on 3 platforms we follow.

Candriam Equities L Oncology I GBP Cap — its category

Sector Equity Healthcare — PowerFunds rates 229 funds in this category every month.

Healthcare funds →

Other funds